Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | PRNP | P04156 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590656 | 1.00 | HSP90AA1 (0.46) | HSP90AA1TLR9GABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL7787482 | 0.82 | GABRA1 (0.44) | HSP90AA1TLR9GABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL26667643 | 0.81 | HSP90AA1 (0.38) | HSP90AA1TLR9SMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL882732 | 0.80 | PYCR1 (0.47) | HSP90AA1TLR9GABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL12798321 | 0.80 | S100A4 (0.46) | HSP90AA1TLR9GABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL1047304 | 0.80 | HSP90AA1 (0.46) | HSP90AA1TLR9SMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL28808700 | 0.79 | HSP90AA1 (0.44) | HSP90AA1TLR9L3MBTL1TSHRS100A4 | |
| SCHEMBL11797035 | 0.78 | TRPA1 (0.43) | GABRA1GABRB2SMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL4882598 | 0.78 | GABRA1 (0.41) | GABRA1GABRB2SMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL8365116 | 0.78 | SMN1; SMN2 (0.41) | GABRA1GABRB2SMN1; SMN2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250374741-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORP (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4479479-B1 | SILPHENYLENE POLYMERS | WACKER CHEMIE AG (DE) | 2025-08-13 | — | — | EP | disclosed |
| US-20250215260-A1 | SILPHENYLENE POLYMERS | WACKER CHEMIE AG (DE) | 2025-07-03 | — | — | US | disclosed |
| EP-4479479-A1 | SILPHENYLENE POLYMERS | Wacker Chemie AG (DE) | 2024-12-25 | — | — | EP | disclosed |
| WO-2024185812-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| US-11858880-B2 | Anti-fungals compounds targeting the synthesis of fungal sphingolipids | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023222203-A1 | SILPHENYLENE POLYMERS | WACKER CHEMIE AG (DE) | 2023-11-23 | — | — | WO | disclosed |
| US-20230295139-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS | UNIVERSITY OF KWAZULU-NATAL (ZA) | 2023-09-21 | — | — | US | disclosed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| EP-0023314-B1 | PROCESS FOR PREPARING POLY(ARYLENE SULFIDES) | BAYER AG (DE) | 1983-07-20 | — | — | EP | disclosed |
| EP-0075769-A1 | Process for producing poly-arylene sulfides | BAYER AG (DE) | 1983-04-06 | — | — | EP | disclosed |
| US-4362864-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1982-12-07 | — | — | US | disclosed |
| EP-0065689-A1 | Method of producing poly(arylene sulfides) | BAYER AG (DE) | 1982-12-01 | — | — | EP | disclosed |
| US-4331801-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-25 | — | — | US | disclosed |
| EP-0040747-A2 | Process for preparing polyarylene sulfides | BAYER AG (DE) | 1981-12-02 | — | — | EP | disclosed |
| US-4303781-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-01 | — | — | US | disclosed |
| EP-0023314-A1 | Process for preparing poly(arylene sulfides) | BAYER AG (DE) | 1981-02-04 | — | — | EP | disclosed |
| EP-0023313-A1 | Process for preparing poly(arylene sulfides) | BAYER AG (DE) | 1981-02-04 | — | — | EP | disclosed |
| US-3939084-A | Functional fluid compositions containing substituted pyrimidines | MONSANTO COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11858880-B2 | Anti-fungals compounds targeting the synthesis of fungal sphingolipids | ERG28, UGCG, DPM1 | HSP90AA1 3181/4885TLR9 4209/4885GABRA1 4267/4885 |
| US-20230295139-A1 | SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS | NAAA, CNR2, AADAC | HSP90AA1 2107/4885TLR9 3297/4885GABRA1 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.